BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 19738063)

  • 21. ApcMin/+ mouse model of colon cancer: gene expression profiling in tumors.
    Leclerc D; Deng L; Trasler J; Rozen R
    J Cell Biochem; 2004 Dec; 93(6):1242-54. PubMed ID: 15486983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
    Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
    Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
    Huang J; Che MI; Huang YT; Shyu MK; Huang YM; Wu YM; Lin WC; Huang PH; Liang JT; Lee PH; Huang MC
    Carcinogenesis; 2009 Aug; 30(8):1452-8. PubMed ID: 19520792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons.
    Zilberberg A; Lahav L; Rosin-Arbesfeld R
    Gut; 2010 Apr; 59(4):496-507. PubMed ID: 19951906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.
    Cortina C; Palomo-Ponce S; Iglesias M; Fernández-Masip JL; Vivancos A; Whissell G; Humà M; Peiró N; Gallego L; Jonkheer S; Davy A; Lloreta J; Sancho E; Batlle E
    Nat Genet; 2007 Nov; 39(11):1376-83. PubMed ID: 17906625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
    Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apc mice: models, modifiers and mutants.
    McCart AE; Vickaryous NK; Silver A
    Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
    Alazzouzi H; Davalos V; Kokko A; Domingo E; Woerner SM; Wilson AJ; Konrad L; Laiho P; Espín E; Armengol M; Imai K; Yamamoto H; Mariadason JM; Gebert JF; Aaltonen LA; Schwartz S; Arango D
    Cancer Res; 2005 Nov; 65(22):10170-3. PubMed ID: 16288001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma.
    Cheung AK; Lung HL; Hung SC; Law EW; Cheng Y; Yau WL; Bangarusamy DK; Miller LD; Liu ET; Shao JY; Kou CW; Chua D; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
    Cancer Res; 2008 Oct; 68(19):8137-45. PubMed ID: 18829573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.
    Cho NL; Javid SH; Carothers AM; Redston M; Bertagnolli MM
    Cancer Res; 2007 Mar; 67(5):2366-72. PubMed ID: 17332369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium.
    Ding S; McEntee MF; Whelan J; Zemel M
    Nutr Cancer; 2007; 58(2):153-61. PubMed ID: 17640161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
    Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
    Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor.
    Kurzik-Dumke U; Hörner M; Czaja J; Nicotra MR; Simiantonaki N; Koslowski M; Natali PG
    Int J Mol Med; 2008 Jan; 21(1):19-31. PubMed ID: 18097612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver.
    Steffensen IL; Schut HA; Alexander J
    Mutat Res; 2005 Nov; 587(1-2):73-89. PubMed ID: 16202642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis.
    Nittka S; Günther J; Ebisch C; Erbersdobler A; Neumaier M
    Oncogene; 2004 Dec; 23(58):9306-13. PubMed ID: 15568039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
    Martínez-Iglesias O; Garcia-Silva S; Tenbaum SP; Regadera J; Larcher F; Paramio JM; Vennström B; Aranda A
    Cancer Res; 2009 Jan; 69(2):501-9. PubMed ID: 19147563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis.
    Yerushalmi HF; Besselsen DG; Ignatenko NA; Blohm-Mangone KA; Padilla-Torres JL; Stringer DE; Cui H; Holubec H; Payne CM; Gerner EW
    Mol Carcinog; 2006 Feb; 45(2):93-105. PubMed ID: 16329147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
    Garneau H; Paquin MC; Carrier JC; Rivard N
    J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.